ALIGOS THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by ALIGOS THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14HHLR ADVISORS, LTD.Aligos Therapeutics, Inc.5,971,4268.2%EDGAR
SC 13G/A2024-02-14EcoR1 Capital, LLCAligos Therapeutics, Inc.7,264,14710.0%EDGAR
SC 13G/A2024-02-14BAKER BROS. ADVISORS LPAligos Therapeutics, Inc.3,664,0135.0%EDGAR
SC 13G/A2024-02-14TANG CAPITAL PARTNERS LPAligos Therapeutics, Inc.2,189,8473.0%EDGAR
SC 13G2024-02-14Alyeska Investment Group, L.P.Aligos Therapeutics, Inc.7,176,76710.0%EDGAR
SC 13G2024-02-14ARMISTICE CAPITAL, LLCAligos Therapeutics, Inc.7,214,82310.0%EDGAR
SC 13D/A2024-02-08Versant Venture Capital VI, L.P.Aligos Therapeutics, Inc.1,457,9371.9%EDGAR
SC 13G/A2023-11-07ROCHE FINANCE LTDAligos Therapeutics, Inc.11,025,94115.4%EDGAR
SC 13D2023-11-06BLATT LAWRENCEAligos Therapeutics, Inc.3,888,2535.3%EDGAR
SC 13G2023-11-02Deep Track Capital, LPAligos Therapeutics, Inc.7,295,96710.0%EDGAR
SC 13G/A2023-02-14HHLR ADVISORS, LTD.Aligos Therapeutics, Inc.2,309,7645.8%EDGAR
SC 13G/A2023-02-14TANG CAPITAL PARTNERS LPAligos Therapeutics, Inc.2,816,3917.1%EDGAR
SC 13G/A2023-02-13EcoR1 Capital, LLCAligos Therapeutics, Inc.3,948,3609.9%EDGAR
SC 13G/A2023-02-09JANUS HENDERSON GROUP PLCAligos Therapeutics, Inc.00.0%EDGAR
SC 13G/A2023-02-08BLATT LAWRENCEAligos Therapeutics, Inc.2,677,9706.5%EDGAR
SC 13G2022-12-27TANG CAPITAL PARTNERS LPAligos Therapeutics, Inc.2,358,9005.9%EDGAR
SC 13G/A2022-02-14HHLR ADVISORS, LTD.Aligos Therapeutics, Inc.2,365,0645.6%EDGAR
SC 13G/A2022-02-14Logos Global Management LPAligos Therapeutics, Inc.-0.0%EDGAR
SC 13G2022-02-14EcoR1 Capital, LLCAligos Therapeutics, Inc.3,213,3007.5%EDGAR
SC 13G2022-02-14BAKER BROS. ADVISORS LPAligos Therapeutics, Inc.2,076,4005.3%EDGAR
External links